Fabrazyme

Fabrazyme Indications/Uses

agalsidase beta

Manufacturer:

Distributor:

DKSH

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Indications/Uses

Fabrazyme (agalsidase beta) is indicated for use in patients with Fabry disease. Fabrazyme reduces globotriaosylceramide (GL-3) deposition in capillary endothelium of the kidney and certain other cell types.

Continue with Google

Already a member? Sign In

Fabrazyme Indications/Uses

agalsidase beta

Manufacturer:

Sanofi-Aventis

Distributor:

DKSH